US Health Secretary RFK Jr to expand access to unapproved peptides

Health experts have cautioned against use of the drugs, citing a lack of clinical trials for humans and the unknown long-term effects.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.